QGAI vs QCRH: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

QCRH has stronger fundamentals based on our AI analysis.

QGAI
Quantumzyme Corp.
STRONG SELL
98%
Confidence
VS
QCRH
QCR HOLDINGS INC
BUY
75%
Confidence

QGAI vs QCRH Fundamental Comparison

Metric QGAI QCRH
Revenue $0.0 $489.4M
Net Income $-4.4M $127.2M
Net Margin N/A 26.0%
ROE N/A 11.4%
ROA -7,422,923.7% 1.3%
Current Ratio 0.00x N/A
Debt/Equity N/A 0.00x
EPS $-0.11 $7.49

Green = Better metric | Red = Weaker metric

View Full QGAI Analysis →
View Full QCRH Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

QGAI vs AAPL QCRH vs MSFT QGAI vs GOOGL QCRH vs AMZN

QGAI vs QCRH: Frequently Asked Questions

Is QGAI or QCRH a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), QCRH has stronger fundamentals. QGAI is rated STRONG SELL (98% confidence) while QCRH is rated BUY (75% confidence). This is not investment advice.

How does QGAI compare to QCRH fundamentally?

Quantumzyme Corp. has ROE of N/A vs QCR HOLDINGS INC's 11.4%. Net margins are N/A vs 26.0% respectively.

Which stock pays higher dividends, QGAI or QCRH?

QGAI has a dividend yield of N/A or no dividend while QCRH has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in QGAI or QCRH for long term?

For long-term investing, consider that QGAI has STRONG SELL rating with 98% confidence, while QCRH has BUY rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about QGAI vs QCRH?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For QGAI vs QCRH, the AI consensus favors QCRH based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.